SAN ANTONIO–(BUSINESS WIRE)–bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, ...
News
- bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales | citybiz
- FibroGen: Q3 Earnings Snapshot - MySA
The biotech drug developer posted revenue of $40.1 million in the period ... San Antonio Toyota workers see raises amid UAW deals · The UAW has its ...
- 22nd Century: Q3 Earnings Snapshot - MySA
The plant biotechnology company posted revenue of $17.8 million in the period, missing Street forecasts. ... San Antonio Toyota workers see raises amid ...
- SA biotech hire to bolster national expansion - San Antonio Business Journal
One of his chief roles will be to identify new business opportunities for the San Antonio biotech and its core technology. Coleman's résumé also ...
- bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales | News
SAN ANTONIO--(BUSINESS WIRE)--Nov 6, 2023--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for ...